Daily Ards Research Analysis
Three studies advance ARDS/ALI science across mechanistic, translational, and therapeutic axes. A Redox Biology paper identifies MOTS-c as a nuclear-acting antioxidant regulator and perioperative biomarker predicting CPB-associated ARDS, while two preclinical studies show that rutin (via cGAS-STING-NLRP3 suppression) and vitamin E (via AMPK/NRF2/NF-κB and macrophage reprogramming) mitigate LPS-induced lung injury.
Summary
Three studies advance ARDS/ALI science across mechanistic, translational, and therapeutic axes. A Redox Biology paper identifies MOTS-c as a nuclear-acting antioxidant regulator and perioperative biomarker predicting CPB-associated ARDS, while two preclinical studies show that rutin (via cGAS-STING-NLRP3 suppression) and vitamin E (via AMPK/NRF2/NF-κB and macrophage reprogramming) mitigate LPS-induced lung injury.
Research Themes
- Mitochondrial-derived peptide MOTS-c as antioxidant transcriptional activator and ARDS biomarker after CPB
- Targeting cGAS-STING-NLRP3 axis to attenuate inflammatory lung injury
- Redox signaling and macrophage polarization as therapeutic levers in ALI/ARDS
Selected Articles
1. MOTS-c attenuates lung ischemia-reperfusion injury via MYH9-Dependent nuclear translocation and transcriptional activation of antioxidant genes.
In rat LIRI, MOTS-c translocates to the nucleus via MYH9 following ROS/CK2A-dependent MYH9 phosphorylation and directly engages ARE-containing promoters (e.g., HMOX1, NQO1) to activate antioxidant defenses. Clinically, perioperative ΔMOTS-c within 24 h post-CPB predicted ARDS (AUC 0.885), and exogenous MOTS-c reduced lung injury, inflammation, oxidative damage, and mortality in vivo.
Impact: This study links a mitochondrial peptide to nuclear antioxidant transcription, explains endothelial protection in LIRI, and introduces a perioperative biomarker with strong predictive performance for ARDS after CPB.
Clinical Implications: ΔMOTS-c could enable early risk stratification for CPB-associated ARDS and guide preventive strategies; MOTS-c analogs merit evaluation as prophylactic adjuncts to reduce LIRI-related complications.
Key Findings
- Endothelial cells showed prominent MOTS-c upregulation in rat LIRI with barrier preservation and reduced oxidative stress.
- ROS-CK2A-mediated phosphorylation of MYH9 (Ser1943) enabled MOTS-c binding to MYH9–γ-Actin complexes for nuclear transport.
- ChIP-seq and RNA-seq demonstrated MOTS-c occupancy at ARE-containing promoters (HMOX1, NQO1) and activation of antioxidant programs.
- Perioperative ΔMOTS-c within 24 h post-CPB predicted ARDS with AUC 0.885; multivariate models with ΔMOTS-c outperformed traditional biomarkers.
- Exogenous MOTS-c administration reduced lung injury, inflammation, oxidative damage, and mortality in vivo.
Methodological Strengths
- Integrated multi-omics (RNA-seq, ChIP-seq) with in vivo LIRI models and mechanistic signaling dissection
- Translational bridge with human perioperative biomarker analysis and predictive modeling
Limitations
- Human cohort size and external validation details are not reported, limiting generalizability
- No randomized clinical testing of MOTS-c therapy; species differences may affect translation
Future Directions: Prospective multicenter validation of ΔMOTS-c for ARDS prediction and phase I/II trials of MOTS-c or analogs for perioperative prophylaxis in high-risk CPB patients.
Acute respiratory distress syndrome (ARDS) following cardiopulmonary bypass (CPB) is driven by oxidative stress during lung ischemia-reperfusion injury (LIRI). Mitochondrial-derived peptide MOTS-c has emerged as a regulator of mitochondrial-nuclear communication, yet its role in CPB-induced ARDS remains unclear. Here, we identify MOTS-c as a critical mediator of endothelial protection against LIRI through MYH9-dependent nuclear translocation and transcriptional activation of antioxidant genes. In rat LIRI models, endo
2. Rutin ameliorates LPS-induced acute lung injury in mice by inhibiting the cGAS-STING-NLRP3 signaling pathway.
In LPS-ALI mice, proteomics highlighted dysregulation of cytosolic DNA-sensing and NOD-like receptor pathways. Rutin reduced lung injury, oxidative stress, apoptosis, and proinflammatory cytokines, while dual-suppressing cGAS-STING (cGAS, STING, p-TBK1/p-IRF3) and NLRP3 pyroptosis (NLRP3–ASC–caspase-1–GSDMD). Pharmacologic STING blockade (C-176) confirmed pathway hierarchy.
Impact: Defines a dual-target anti-inflammatory mechanism for a widely available flavonoid in ALI, prioritizing the cGAS-STING–NLRP3 axis as a druggable pathway in ARDS/ALI.
Clinical Implications: Supports development of cGAS-STING/NLRP3-targeted strategies and positions rutin (or derivatives) as potential adjuncts for early ALI/ARDS management pending human studies.
Key Findings
- Proteomics showed activation of cGAS-STING and pyroptosis-related proteins in LPS-ALI lung tissue.
- Rutin reduced oxidative stress, apoptosis, and inflammatory cytokines (IL-6, IL-1β, TNF-α).
- Mechanistically, rutin inhibited cGAS, STING, and phosphorylation of TBK1/IRF3, and downregulated NLRP3–ASC–caspase-1–GSDMD signaling.
- STING inhibitor C-176 validated the cGAS-STING–NLRP3 regulatory hierarchy in ALI pathogenesis.
Methodological Strengths
- Comprehensive proteomics integrated with histology, molecular assays, and in vivo functional readouts
- Pharmacologic pathway validation using a selective STING inhibitor (C-176)
Limitations
- Single-species preclinical model without dose-response or pharmacokinetic bridging to humans
- Lack of long-term outcomes and external replication
Future Directions: Define dosing, PK/PD, and safety of rutin/analogs; test combinations with standard ARDS care; and evaluate cGAS-STING/NLRP3 signatures and response biomarkers in patients.
INTRODUCTION: Acute lung injury (ALI) and its severe form, acute respiratory distress syndrome (ARDS), represent critical respiratory failures with high mortality rates and limited treatment options. While the flavonoid rutin exhibits documented anti-inflammatory and antioxidant properties, its therapeutic mechanisms in ALI/ARDS remain unclear. This study investigated rutin's efficacy against lipopolysaccharide (LPS)-induced ALI in mice, with a mechanistic focus on the cGAS-STING pathway and NLRP3 inflammasome
3. Vitamin E exerts a mitigating effect on LPS-induced acute lung injury by regulating macrophage polarization through the AMPK/NRF2/NF-κB pathway.
Vitamin E reduced injury indices and proinflammatory mediators in LPS-ALI, improved survival, and mitigated oxidative stress. Mechanistically, it activated AMPK, upregulated NRF2, inhibited NF-κB, scavenged ROS, and shifted macrophage polarization toward anti-inflammatory M2 while suppressing M1.
Impact: Identifies a redox-immune axis by which a clinically accessible antioxidant modulates macrophage polarization to blunt ALI, supporting repurposing strategies.
Clinical Implications: Supports testing vitamin E or analogs as adjunctive therapy in early ALI/ARDS and encourages macrophage-targeted strategies alongside standard care.
Key Findings
- Vitamin E decreased lung wet/dry ratio, reduced BALF proinflammatory cytokines, and improved survival in LPS-ALI mice.
- It alleviated oxidative stress by modulating redox products and scavenging ROS.
- Activated AMPK, upregulated NRF2, inhibited NF-κB signaling, and reprogrammed macrophage polarization toward M2 while suppressing M1.
Methodological Strengths
- Combined in vivo ALI model with in vitro BMDM mechanistic assays
- Demonstrated survival benefit alongside molecular pathway validation
Limitations
- Translational dosing and pharmacokinetics for humans are not defined
- Single animal model and strain; lack of long-term and multi-species validation
Future Directions: Determine optimal dosing and formulation, assess synergy with lung-protective ventilation and steroids, and conduct early-phase clinical studies in high-risk ALI/ARDS.
Acute Lung Injury (ALI) and its severe manifestation, acute respiratory distress syndrome (ARDS), are major threats to human health, characterized by high mortality rates and a lack of effective treatments. Given the significant role of an over-activated inflammatory response and macrophage polarization in the development of ALI, and the unknown effect of vitamin E in this context, our study aimed to explore vitamin E's potential in alleviating ALI. We established an ALI mouse model by intratracheal instilla